# Endoso Life

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/endoso-life

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.endoso.com.cn
- Total disclosed funding: $14M
- Latest round: Series A (Jan 22, 2024)
- Investors on record: 2

## About

Established in 2020 and based in Hangzhou, China, Endoso Life is a medical device company that focuses on developing and marketing minimally invasive medical devices. The company has set up branch offices in Shenzhen and Xiangtan. It has three R&D centers, with more than 50 medical device R&D experts and 3,000 square meters of sterile medical device production facilities. Endoso has applied over 30 patents. In January 2020, its F-Series electronic endoscope processors were approved for market launch. In January 2024, Endoso Life raised over CNY 100 million in series A funding.

The company's main business is medical endoscopy systems and related innovative product development, production and sales. Its self-developed products include rigid endoscopy systems such as image processing systems and rigid endoscopes. Their products are used in the field of general surgery, urology, gynecology, gastroenterology and respiratory medicine.

The company will expand the product matrix of rigid and disposable endoscopes and accelerate the globalization of sales channels.

## Funding rounds

- Series A, Jan 22, 2024, $14M — Lapam Capital, Wego Capital

## Investors

- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Series A
- Wego Capital (https://capitalatlas.ai/funds/wego-capital) — Series A